Form D · Pharmaceuticals
AGILE THERAPEUTICS INC
Princeton, NJ · CIK 0001261249
Offering snapshot reported Mar 14, 2019 · SEC filing
- Reported sold
- $7.84M Offering amount: $7.84M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 14, 2019 | Initial | $7,836,878 | No comparison | 1 | SEC filing |
| Feb 6, 2015 | Initial | $20,000,000 | No comparison | 8 | SEC filing |
| May 9, 2014 | Initial | $3,000,000 | No comparison | 9 | SEC filing |
| Jul 31, 2012 | Initial | $23,676,000 | No comparison | 13 | SEC filing |
| Jul 11, 2011 | Amendment | $33,060,670 | $9,716,642vs Jun 7, 2010 | 14 | SEC filing |
| Jun 7, 2010 | Initial | $23,344,028 | No comparison | 11 | SEC filing |
| May 5, 2010 | Initial | $989,178 | No comparison | 6 | SEC filing |
| Jan 12, 2010 | Initial | $1,010,822 | No comparison | 14 | SEC filing |
| Oct 28, 2009 | Initial | $1,005,000 | No comparison | 11 | SEC filing |
| Jan 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-334871
Source: Form D, filed Mar 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Al Altomari | Director, Executive |
| Russell W. Ayres | Director |
| Daria O. Blackwell | Director |
| Scott M. Coiante | Executive |
| Robert G. Conway | Executive |
| Seth H.Z. Fischer | Director |
| Elizabeth Garner | Executive |
| Geoffrey P. Gilmore | Executive |
| Karen Hong | Director |
| John Hubbard | Director |
| Devang V. Kantesaria | Director |
| Abhijeet Lele | Director |
| Abhijeet Le Le | Director |
| Katie Mac Farlane | Executive |
| William T. Mc Kee | Director |
| Dean Miller | Director |
| Lorenzo Pellegrini | Director |
| Thomas M. Rossi | Director, Executive |
| Andrew N. Schiff | Director |
| Paul J. Schmitt | Director |
| Ajit S. Shetty | Director |
| Joyce Tsang | Director |
| James P. Tursi | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
101 Poor Farm Road
Princeton, NJ, 08540-1715
Princeton, NJ, 08540-1715